Bellucci et al.28 characterized BCMA expression in primary tumor samples from MM patients (n = 33) and in purified CD138+ plasma cells from MGUS patients (n = 5) and normal plasma cells (n = 5) using high-density oligonucleotide microarrays. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.